3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
11
Esophageal Neoplasms
11
Uterine Cervical Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Head and Neck Neoplasms
7
Pancreatic Neoplasms
6
Oropharyngeal Neoplasms
6
Nasopharyngeal Carcinoma
6
Carcinoma, Squamous Cell
5
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Thymoma
2
Stomach Neoplasms
2
Neoplasms by Site
2
Neoplasms
2
NSCLC
2
Lymphoma
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Thrombocytopenia
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
SCLC, Extensive Stage
1
Resectable Esophageal Cancer
1
Rectal Malignant Neoplasms
1
Interventions
Chemoradiotherapy
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Resectable Esophageal Cancer
×
Chemoradiotherapy
×
Clear all
NCT07385664
2026-02-04
FAIR
Zhejiang Cancer Hospital
Phase 2
Not yet recruiting
66 enrolled